Trial Profile
Phase I, randomised, double-blind, placebo-controlled, multiple ascending dose (MAD) study evaluating the pharmacodynamics and tolerability of subcutaneous RM 131 in healthy volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 18 Apr 2013
Price :
$35
*
At a glance
- Drugs Relamorelin (Primary)
- Indications Diabetic gastroparesis
- Focus Adverse reactions; Pharmacodynamics
- 18 Apr 2013 New trial record